OverviewSuggest Edit

Abbott India is a pharmaceutical company that offers medicinal drugs. It offers medicines in multiple therapeutic categories such as women's health, gastroenterology, cardiology, metabolic disorders, and primary care.
TypePublic
Founded1944
HQMumbai, IN
Websiteabbott.co.in

Latest Updates

Employees (est.) (Dec 2019)3,551(+2%)
Revenue (FY, 2020)₹40.9 B(+12%)
Share Price (Jun 2021)₹15.9 K
Cybersecurity ratingAMore

Key People/Management at Abbott India

Anil Joseph

Anil Joseph

Managing Director
Rajiv Sonalker

Rajiv Sonalker

CFO and Whole-Time Director
Sridhar Kadangode

Sridhar Kadangode

Director - Finance
Vijay Patil

Vijay Patil

Associate Director – New Product Introductions and Therapy Area Strategy
Srirupa Das

Srirupa Das

Director – Medical Affairs
Keya Phatnani

Keya Phatnani

Director – Business Human Resources
Show more

Abbott India Office Locations

Abbott India has offices in Mumbai and Verna
Mumbai, IN (HQ)
3-4, Corporate Park, Sion-Trombay Road, Chembur, Swastik Park, Chembur
Mumbai, IN
Plot C-68, G Block BKC, Bandra Kurla Complex, Bandra East
Verna, IN
Verna Industrial Estate
Show all (3)

Abbott India Financials and Metrics

Abbott India Revenue

Embed Graph
View revenue for all periods
Abbott India's revenue was reported to be ₹40.93 b in FY, 2020 which is a 11.3% increase from the previous period.
INR

Revenue (Q3, 2021)

11.0b

Gross profit (Q3, 2021)

5.0b

Gross profit margin (Q3, 2021), %

45.3%

Net income (Q3, 2021)

1.8b

Market capitalization (7-Jun-2021)

338.0b

Closing stock price (7-Jun-2021)

15.9k

Cash (30-Sept-2020)

1.9b

EV

337.7b
Abbott India's current market capitalization is ₹338 b.
Annual
INRFY, 2018FY, 2019FY, 2020

Revenue

33.1b36.8b40.9b

Revenue growth, %

11%11%

Cost of goods sold

19.0b20.9b23.2b

Gross profit

14.0b15.9b17.8b
Quarterly
INRQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021

Revenue

8.4b9.8b9.5b10.0b10.5b10.8b10.6b10.5b11.0b

Cost of goods sold

4.8b5.6b5.5b5.6b6.0b6.0b6.1b5.8b6.0b

Gross profit

3.7b4.2b4.0b4.4b4.5b4.8b4.5b4.8b5.0b

Gross profit Margin, %

44%43%42%44%43%45%43%45%45%
Annual
INRFY, 2018FY, 2019FY, 2020

Cash

376.8m1.4b1.5b

Accounts Receivable

2.6b2.8b3.2b

Inventories

5.9b6.1b5.3b

Current Assets

22.7b27.6b32.0b
Half Year
INRH1, 2019H1, 2020H1, 2021

Cash

1.4b2.7b1.9b

Accounts Receivable

2.7b3.1b3.4b

Inventories

5.6b6.3b6.9b

Current Assets

25.6b29.7b31.4b
Annual
INRFY, 2018FY, 2019FY, 2020

Net Income

4.0b4.5b5.9b

Depreciation and Amortization

145.0m158.0m596.1m

Inventories

(847.0m)(214.6m)796.2m

Accounts Payable

47.8m1.9b(85.1m)
Half Year
INRH1, 2019H1, 2020H1, 2021

Net Income

2.2b3.0b3.6b

Depreciation and Amortization

80.5m297.5m283.9m

Inventories

213.7m(203.2m)(1.6b)

Accounts Payable

1.7b361.9m424.1m
INRFY, 2018

Revenue/Employee

10.0m

Financial Leverage

1.4 x
Show all financial metrics

Abbott India Revenue Breakdown

Embed Graph

Abbott India revenue breakdown by business segment: 99.1% from Products and 0.9% from Other

Abbott India Cybersecurity Score

Cybersecurity ratingPremium dataset

A

90/100

SecurityScorecard logo

Abbott India Online and Social Media Presence

Embed Graph

Abbott India News and Updates

Abbott India - Sales Recovery In The Offing: ICICI Direct

Abbott India - Sales Recovery In The Offing: ICICI Direct

Abbott Collaborates with Nutrition Society of India to Create Awareness on Clinical Dietary Recommendations for GI Patients

Abbott partnered with Nutrition Society of India (NSI) to create awareness for the first-ever India-specific clinical dietary recommendations for patients suffering from GI conditions, ranging from functional constipation and peptic ulcers to obesity, chronic pancreatitis and irritable bowel syndrom…

Abbott Forms Pandemic Defense Coalition to Help Prevent Future Pandemics and Searching for Covid-19 Variants

Abbott has formed the Abbott Pandemic Defense Coalition, a “first-of-its-kind” global scientific and public health partnership for the early detection of, and rapid response to, future pandemic threats. By connecting global centres of excellence in laboratory testing, genetic sequencing and public h…

Abbott India Q3 Results: Net Profit Falls 5% to Rs 177 cr

Drug firm Abbott India on Tuesday reported a 5.11 percent decline in its net profit to Rs 177.14 crore for the quarter ended December

Abbott India Frequently Asked Questions

  • When was Abbott India founded?

    Abbott India was founded in 1944.

  • Who are Abbott India key executives?

    Abbott India's key executives are Anil Joseph, Rajiv Sonalker and Sridhar Kadangode.

  • How many employees does Abbott India have?

    Abbott India has 3,551 employees.

  • What is Abbott India revenue?

    Latest Abbott India annual revenue is ₹40.9 b.

  • What is Abbott India revenue per employee?

    Latest Abbott India revenue per employee is ₹11.5 m.

  • Who are Abbott India competitors?

    Competitors of Abbott India include Alkem Laboratories, Neuland Laboratories and Cadila Healthcare.

  • Where is Abbott India headquarters?

    Abbott India headquarters is located at 3-4, Corporate Park, Sion-Trombay Road, Chembur, Swastik Park, Chembur, Mumbai.

  • Where are Abbott India offices?

    Abbott India has offices in Mumbai and Verna.

  • How many offices does Abbott India have?

    Abbott India has 3 offices.